ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,914.45
-0.94%
US Tech 100
20,616.04
-1.37%
Dow Jones
42,612.40
-0.88%
Brent Oil
74.185
0.76%
Bitcoin
91,912.80
-1.71%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Comera Life Sciences Holdings Inc (CMRA) Quote

Comera Life Sciences Holdings Inc

Comera Life Sciences Holdings Inc (CMRA)

Comera Life Sciences Holdings Inc (CE)
0.045
0.00
( 0.00% )
Updated: 19:00:00
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
0.045
Bid
0.0451
Ask
0.065
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Market Cap
1.383M
Previous Close
0.045
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
30,737,796
Dividend Yield
-
PE Ratio
-0.07
Earnings Per Share (EPS)
-0.6
Revenue
633k
Net Profit
-18.38M

About Comera Life Sciences Holdings Inc

Comera Life Sciences Holdings Inc is a pre-clinical biotechnology company dedicated to promoting a formulation science and technology to transform essential biologic medicines from intravenous to subcutaneous forms. Comera's internal portfolio of proprietary techniques known as the SQore platform is... Comera Life Sciences Holdings Inc is a pre-clinical biotechnology company dedicated to promoting a formulation science and technology to transform essential biologic medicines from intravenous to subcutaneous forms. Comera's internal portfolio of proprietary techniques known as the SQore platform is designed to potentially transform essential biologic medicines from intravenous (IV) to subcutaneous (SQ) forms, and optimize current versions of subcutaneous biologics, and produce biosimilar versions of existing subcutaneous products. It also collaborates with pharmaceutical and biotechnology companies, applying the SQore platform to the Company's partners' biologic medicines to deliver enhanced formulations that facilitate self-injectable care. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
comeralifesciences.com
Headquarters
Wilmington, Delaware, USA
Founded
-

Ask ADVFN Intelligence (AI)

CMRA Latest News

More News

Comera Life Sciences Announces Bridge Financing and Exercise of Take Private Option

WOBURN, Mass., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (OTCQB: CMRA) (“Comera” or the “Company”), a life sciences company developing a proprietary drug-delivery...

January 04 2024
GlobeNewswire Inc.

Comera Life Sciences Announces Process Exploring Strategic Alternatives

WOBURN, Mass., Dec. 06, 2023 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (OTCQB: CMRA) (“Comera” or the “Company”), a life sciences company developing a new generation of biologic...

December 06 2023
GlobeNewswire Inc.

Comera Life Sciences Appoints Dorothy Clarke to Board of Directors

WOBURN, Mass., Nov. 13, 2023 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), a life sciences company developing a new generation of biologic medicines to improve...

November 13 2023
GlobeNewswire Inc.

Comera Life Sciences Reports Financial Results for Third Quarter 2023 and Recent Business Highlights

– Final stage of technical evaluation near completion in Comera’s research collaboration with Regeneron, a leading U.S. biotechnology company – – Expanded and strengthened Comera’s global patent...

November 09 2023
GlobeNewswire Inc.

Comera Life Sciences Presents SQore™ Platform Technology Data at PODD: Partnerships in Drug Delivery Conference

WOBURN, Mass., Oct. 16, 2023 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), a life sciences company developing a new generation of biologic medicines to improve patient...

October 16 2023
GlobeNewswire Inc.

Comera Life Sciences Announces the Completion of $4.1 Million Private Placement

WOBURN, Mass., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), a life sciences company developing a new generation of biologic medicines to improve patient...

September 12 2023
GlobeNewswire Inc.

Comera Life Sciences Announces Publication of Study Reinforcing Caffeine’s Viscosity Reducing Capabilities

Data published in the Journal of Pharmaceutical Sciences support further development of caffeine as a viscosity reducing agent for subcutaneous formulations of monoclonal antibodies WOBURN...

August 16 2023
GlobeNewswire Inc.

Comera Life Sciences Reports Financial Results for Second Quarter 2023 and Recent Business Highlights

– Advanced to final stage of technical evaluation in Comera’s research collaboration with Regeneron, a leading U.S. biotechnology company – – Received notice that Nasdaq granted Comera’s request...

August 10 2023
GlobeNewswire Inc.

Comera Life Sciences Significantly Expands Intellectual Property Portfolio Strengthening the Proprietary SQore™ Platform

WOBURN, Mass., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), a life sciences company developing a new generation of biologic medicines to improve patient...

August 08 2023
GlobeNewswire Inc.

Comera Life Sciences Announces $4.1 Million Private Placement

WOBURN, Mass., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), a life sciences company developing a new generation of biologic medicines to improve patient...

August 01 2023
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

CMRA - Frequently Asked Questions (FAQ)

What is the current Comera Life Sciences share price?
The current share price of Comera Life Sciences is $ 0.045
How many Comera Life Sciences shares are in issue?
Comera Life Sciences has 30,737,796 shares in issue
What is the market cap of Comera Life Sciences?
The market capitalisation of Comera Life Sciences is USD 1.38M
What is the 1 year trading range for Comera Life Sciences share price?
Comera Life Sciences has traded in the range of $ 0.00 to $ 0.00 during the past year
What is the PE ratio of Comera Life Sciences?
The price to earnings ratio of Comera Life Sciences is -0.07
What is the cash to sales ratio of Comera Life Sciences?
The cash to sales ratio of Comera Life Sciences is 1.94
What is the reporting currency for Comera Life Sciences?
Comera Life Sciences reports financial results in USD
What is the latest annual turnover for Comera Life Sciences?
The latest annual turnover of Comera Life Sciences is USD 633k
What is the latest annual profit for Comera Life Sciences?
The latest annual profit of Comera Life Sciences is USD -18.38M
What is the registered address of Comera Life Sciences?
The registered address for Comera Life Sciences is 1521 CONCORD PIKE SUITE 201, NEW CASTLE, WILMINGTON, DELAWARE, 19803
What is the Comera Life Sciences website address?
The website address for Comera Life Sciences is comeralifesciences.com
Which industry sector does Comera Life Sciences operate in?
Comera Life Sciences operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
NXUNXU Inc
$ 1.03
(323.17%)
303.5M
WATTEnergous Corporation
$ 1.54
(274.51%)
152.25M
INTZIntrusion Inc
$ 5.48
(153.70%)
103.81M
CYNCYNGN Inc
$ 1.3534
(115.54%)
46.81M
VINCVincerx Inc
$ 0.3697
(90.57%)
272.63M
ABPAbpro Holdings Inc
$ 2.25
(-49.89%)
926.38k
TRAWTraws Pharma Inc
$ 8.34
(-37.85%)
781.45k
LITMSnow Lake Resources Ltd
$ 1.175
(-26.56%)
40.53M
BITSGlobal X Blockchain and Bitcoin Stratagy ETF
$ 66.40
(-24.94%)
7.25k
LICNLichen China Limited
$ 0.1818
(-21.67%)
25.94M
NXUNXU Inc
$ 1.03
(323.17%)
306.87M
VINCVincerx Inc
$ 0.3697
(90.57%)
272.96M
XTIAXTI Aerospace Inc
$ 0.0399
(1.01%)
153.3M
WATTEnergous Corporation
$ 1.54
(274.51%)
152.99M
INTZIntrusion Inc
$ 5.48
(153.70%)
105.3M

CMRA Discussion

View Posts
Renee Renee 1 year ago
CMRA delisted from the Nasdaq to the OTC. ***PPS dropped 65% from .25 to .085 on the delisting.

https://otce.finra.org/otce/dailyList?viewType=Additions
👍️0
glenn1919 glenn1919 1 year ago
CMRA............................https://stockcharts.com/h-sc/ui?s=CMRA&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 1 year ago
CMRA..............................https://stockcharts.com/h-sc/ui?s=CMRA&p=W&b=5&g=0&id=p86431144783
👍️0
Awl416 Awl416 1 year ago
Don’t blink
👍️0
chumfm chumfm 1 year ago
No volume,not even 20 thousand shares.Wait for it,something is cooking.Good luck and good trading.
👍️0
Monksdream Monksdream 1 year ago
CMRAnew 52 week low
👍️0
Triple nickle Triple nickle 1 year ago
Added to the stash
👍️0
Invest-in-America Invest-in-America 1 year ago
CMRA: Why is this going up?? Heck, see ME below --- proudly deploying new, "DD-Amanda-Vers-7.5-Stock-News-GUESSING-Gadet"!!!


"I see a looming Medical Science JOINT-VENTURE!! Between the cute little CMRA Firm, and --- you will simply not believe it(!!) --- the Health Care COLOSSUS, Johnson & Johnson!! Evidently, to market CMRA's shocking new, Subcutaneous-Human-Genomic-&-Disease-Prevention-Controller!!"
👍️0
Zorro Zorro 1 year ago
https://stocktwits.com/BirdmanCrypto/message/534396942
👍️0
Invest-in-America Invest-in-America 2 years ago
CMRA: (I thought you were at Vegas already, spending that little LOTTO ticket you scored on that silly OTHER stock. !! HAH-HAH!!) Hey, Boss CMRA up by 30% right now --- i.e., nearly midnight here in San Diego --- but my cursory check sees no 'news' about it, per se. Did it hit 100%, just after the Friday Close???

In any event, THANKS for the heads-up, Capt!!! (See ya all, Monday --- to a 1 pm [ET] Close.)
👍️0
subslover subslover 2 years ago
KABOOM!
👍️0
Zorro Zorro 2 years ago
Some good upside volume on the warrants today.
👍️0
Zorro Zorro 2 years ago
This is getting ready for some news.
👍️0
Zorro Zorro 2 years ago
Trying to come off a bottom. Could pop soon.
👍️0
Moe1979 Moe1979 2 years ago
I’m new here. What caused this to tank back in May?
👍️0
trendzone trendzone 2 years ago
$4.00+ breakout setting up that's going to blow out the corrupted shorts that keep trying to manipulate it from going over $4.00, these criminals need to get squeezed and blown up.
👍️0
MoneyAndRun MoneyAndRun 2 years ago
I'm here with you buddy! Crazy how dead this board is?!

Got in at 2.57 for a nice little ride!
👍️0
Invest-in-America Invest-in-America 2 years ago
CMRA: Nobody here, as it goes to the MOON?? O.K., but at least I'M glad that I grabbed a nice chunk of this about 1-hr. ago!!! And SCREW the rest of the World!! RIGHT??????

👍️0
Zorro Zorro 3 years ago
Shot up to over $5 this morning pre-market out of nowhere.
👍️0
akamaii akamaii 3 years ago
Float small I like it for 100 gain easy
👍️0
Zorro Zorro 3 years ago
This is like playing a pinball machine;)
👍️0
akamaii akamaii 3 years ago
I’m in 340 a share the product reminds me of insulin device this is big float small too
👍️0
spindog spindog 3 years ago
I must’ve left the house before the scanner went off
👍️0
spindog spindog 3 years ago
I can’t believe I stepped out to run some errands for a couple hours and missed this beautiful run…errrrt!
👍️0
THEMASTERS_SON THEMASTERS_SON 3 years ago
,,,,,,,First in first post first out..
👍️0

Your Recent History

NASDAQ
CMRA
Comera Life Sciences
BIT
UI481X
UniCredit
BIT
UB6SWA
Unicredit Bank
BIT
NSCIT4447040
Intesa Sanpaolo
LSE
FF30
Close Bros 28
LSE
64RR
Sandwell 1 D
BIT
CLE
Class Editori
ASX
TX3
Trinex Minerals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads